rs199473645
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM5PP3_ModeratePP5
The NM_000219.6(KCNE1):c.199C>T(p.Arg67Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000262 in 1,528,300 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R67H) has been classified as Pathogenic.
Frequency
Consequence
NM_000219.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNE1 | NM_000219.6 | c.199C>T | p.Arg67Cys | missense_variant | 4/4 | ENST00000399286.3 | NP_000210.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNE1 | ENST00000399286.3 | c.199C>T | p.Arg67Cys | missense_variant | 4/4 | 1 | NM_000219.6 | ENSP00000382226 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000374 AC: 5AN: 133706Hom.: 0 Cov.: 17
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251382Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135892
GnomAD4 exome AF: 0.0000251 AC: 35AN: 1394594Hom.: 1 Cov.: 26 AF XY: 0.0000330 AC XY: 23AN XY: 696712
GnomAD4 genome AF: 0.0000374 AC: 5AN: 133706Hom.: 0 Cov.: 17 AF XY: 0.0000155 AC XY: 1AN XY: 64538
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Dec 15, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | KCNE1: PM1, PM5, PS4:Moderate, PM2:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 08, 2022 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; One functional study proposed that p.(R67C) resulted in a LQTS phenotype due to decreased PIP2 sensitivity (Li et al., 2011); another study found that p.(R67C) had no significant effect on channel current compared with wild type (Garmany et al., 2020); This variant is associated with the following publications: (PMID: 24710009, 24631775, 30020974, 19862833, 28018021, 29247119, 25234231, 32058015, 31941373, 19716085, 21576493) - |
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 09, 2021 | Variant summary: KCNE1 c.199C>T (p.Arg67Cys) results in a non-conservative amino acid change located in the C-terminal domain (Kapplinger_2009) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.2e-05 in 251382 control chromosomes. In our cross sectional ascertainment of the literature, c.199C>T has been reported in the literature in cohorts of individuals undergoing comprehensive genetic evaluation for LQTS with a wide variation in age of onset (example, Kapplinger_2009, Wang_2014, Coll_2018, Roberts_2020) and as an uninformative occurrence in a family with congenital heart block that underwent WES (whole exome sequencing) (example, Thongnak_2016). One of these publications reporting a segregation within at-least two affected members from one family classified the variant as a VUS (Roberts_2020). These data indicate that the variant may be associated with disease. At least two publications report conflicting experimental evidence evaluating an impact on protein function (example, Li_2011, Garmany_2020). The most pronounced variant effect results in decreased sensitivity towards phosphatidylinositol 4,5-bisphosphate (PIP2) cofactor required for cardiac slow-delayed rectifier channel activity (Li_2011) while a subsequent study reported no significant differences in rectifying potassium current densities compared to WT (Garmany_2020). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant citing overlapping but not identical evidence utilized in the context of this evalution (likely pathogenic, n=1; VUS, n=2). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 23, 2014 | The Arg67Cys variant in KCNE1 has not previously been reported in any individual s with hearing loss but has been reported in one individual with long QT syndrom e (Kapplinger 2009). This variant was absent from large population studies. Comp utational prediction tools and conservation analyses suggest this variant may im pact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the Arg67Cys variant is uncertain. - |
Long QT syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 67 of the KCNE1 protein (p.Arg67Cys). This variant is present in population databases (rs199473645, gnomAD 0.009%). This missense change has been observed in individuals with clinical features of long QT syndrome and/or sudden unexplained death (PMID: 19716085, 24631775, 29247119, 30020974, 31941373, 32058015; Invitae). ClinVar contains an entry for this variant (Variation ID: 132660). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KCNE1 protein function. Experimental studies have shown that this missense change affects KCNE1 function (PMID: 21576493). For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 04, 2024 | The p.R67C variant (also known as c.199C>T), located in coding exon 1 of the KCNE1 gene, results from a C to T substitution at nucleotide position 199. The arginine at codon 67 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been reported in long QT syndrome and sudden unexplained death cohorts (Hedley PL et al. Hum. Mutat., 2009 Nov;30:1486-511; Kapplinger JD et al. Heart Rhythm. 2009;6(9):1297-303; Wang D et al. Forensic Sci Int. 2014;237:90-9). This variant co-segregated with disease in 1 family tested in our laboratory (Internal Ambry Data). In a study looking at the function of phosphatidylinositol 4,5-biphosphate in potassium channel IKs, p.R67C was shown to cause a reduced current when compared to the wildtype (Li Y, Proc. Natl. Acad. Sci. U.S.A. 2011 May; 108(22):9095-100). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. However, pathogenic and likely pathogenic KCNE1 variants typically exhibit low penetrance in the heterozygous state and may represent risk factors that manifest clinically only in the presence of additional genetic or environmental factors (Roberts JD et al.Circulation. 2020 02;141(6):429-439). - |
Long QT syndrome 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jun 02, 2022 | - - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at